COMPOSTO, USO DO COMPOSTO, E, COMPOSIÇÃO FARMACÊUTICA
The present invention relates to substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators. Depending on the structure and the stereochemistry the compounds of the invention are either selective agonists or selective antagonists of the human melanocortin-4 receptor (MC-4R)....
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | por |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | CHRISTIAN RUMMEY HOLGER DEPPE MIROSLAV TERINEK SONJA NORDHOFF ACHIM FEURER MARCO HENNEBOEHLE MICHAEL SOEBERDT PHILIPP WEYERMANN HERVE SIENDT HOLGER HERZNER |
| description | The present invention relates to substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators. Depending on the structure and the stereochemistry the compounds of the invention are either selective agonists or selective antagonists of the human melanocortin-4 receptor (MC-4R). The agonists can be used for the treatment of disorders and diseases such as obesity, diabetes and sexual dysfunction, whereas the antagonists are useful for the treatment of disorders and diseases such as cancer cachexia, muscle wasting, anorexia, anxiety and depression. Generally all diseases and disorders where the regulation of the MC-4R is involved can be treated with the compounds of the invention. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_BRPI0814382A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BRPI0814382A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_BRPI0814382A23</originalsourceid><addsrcrecordid>eNrjZLBw9vcN8A8O8ddRCA32V3DxV0AIuOpAOZ6H2w83-yu4OQb5Ojof7goN8XR25GFgTUvMKU7lhdLcDEpuriHOHrqpBfnxqcUFicmpeakl8U5BAZ4GFoYmxhZGjkbGRCkCAJBkK1I</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>COMPOSTO, USO DO COMPOSTO, E, COMPOSIÇÃO FARMACÊUTICA</title><source>esp@cenet</source><creator>CHRISTIAN RUMMEY ; HOLGER DEPPE ; MIROSLAV TERINEK ; SONJA NORDHOFF ; ACHIM FEURER ; MARCO HENNEBOEHLE ; MICHAEL SOEBERDT ; PHILIPP WEYERMANN ; HERVE SIENDT ; HOLGER HERZNER</creator><creatorcontrib>CHRISTIAN RUMMEY ; HOLGER DEPPE ; MIROSLAV TERINEK ; SONJA NORDHOFF ; ACHIM FEURER ; MARCO HENNEBOEHLE ; MICHAEL SOEBERDT ; PHILIPP WEYERMANN ; HERVE SIENDT ; HOLGER HERZNER</creatorcontrib><description>The present invention relates to substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators. Depending on the structure and the stereochemistry the compounds of the invention are either selective agonists or selective antagonists of the human melanocortin-4 receptor (MC-4R). The agonists can be used for the treatment of disorders and diseases such as obesity, diabetes and sexual dysfunction, whereas the antagonists are useful for the treatment of disorders and diseases such as cancer cachexia, muscle wasting, anorexia, anxiety and depression. Generally all diseases and disorders where the regulation of the MC-4R is involved can be treated with the compounds of the invention.</description><language>por</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150127&DB=EPODOC&CC=BR&NR=PI0814382A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20150127&DB=EPODOC&CC=BR&NR=PI0814382A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CHRISTIAN RUMMEY</creatorcontrib><creatorcontrib>HOLGER DEPPE</creatorcontrib><creatorcontrib>MIROSLAV TERINEK</creatorcontrib><creatorcontrib>SONJA NORDHOFF</creatorcontrib><creatorcontrib>ACHIM FEURER</creatorcontrib><creatorcontrib>MARCO HENNEBOEHLE</creatorcontrib><creatorcontrib>MICHAEL SOEBERDT</creatorcontrib><creatorcontrib>PHILIPP WEYERMANN</creatorcontrib><creatorcontrib>HERVE SIENDT</creatorcontrib><creatorcontrib>HOLGER HERZNER</creatorcontrib><title>COMPOSTO, USO DO COMPOSTO, E, COMPOSIÇÃO FARMACÊUTICA</title><description>The present invention relates to substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators. Depending on the structure and the stereochemistry the compounds of the invention are either selective agonists or selective antagonists of the human melanocortin-4 receptor (MC-4R). The agonists can be used for the treatment of disorders and diseases such as obesity, diabetes and sexual dysfunction, whereas the antagonists are useful for the treatment of disorders and diseases such as cancer cachexia, muscle wasting, anorexia, anxiety and depression. Generally all diseases and disorders where the regulation of the MC-4R is involved can be treated with the compounds of the invention.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLBw9vcN8A8O8ddRCA32V3DxV0AIuOpAOZ6H2w83-yu4OQb5Ojof7goN8XR25GFgTUvMKU7lhdLcDEpuriHOHrqpBfnxqcUFicmpeakl8U5BAZ4GFoYmxhZGjkbGRCkCAJBkK1I</recordid><startdate>20150127</startdate><enddate>20150127</enddate><creator>CHRISTIAN RUMMEY</creator><creator>HOLGER DEPPE</creator><creator>MIROSLAV TERINEK</creator><creator>SONJA NORDHOFF</creator><creator>ACHIM FEURER</creator><creator>MARCO HENNEBOEHLE</creator><creator>MICHAEL SOEBERDT</creator><creator>PHILIPP WEYERMANN</creator><creator>HERVE SIENDT</creator><creator>HOLGER HERZNER</creator><scope>EVB</scope></search><sort><creationdate>20150127</creationdate><title>COMPOSTO, USO DO COMPOSTO, E, COMPOSIÇÃO FARMACÊUTICA</title><author>CHRISTIAN RUMMEY ; HOLGER DEPPE ; MIROSLAV TERINEK ; SONJA NORDHOFF ; ACHIM FEURER ; MARCO HENNEBOEHLE ; MICHAEL SOEBERDT ; PHILIPP WEYERMANN ; HERVE SIENDT ; HOLGER HERZNER</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_BRPI0814382A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>2015</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CHRISTIAN RUMMEY</creatorcontrib><creatorcontrib>HOLGER DEPPE</creatorcontrib><creatorcontrib>MIROSLAV TERINEK</creatorcontrib><creatorcontrib>SONJA NORDHOFF</creatorcontrib><creatorcontrib>ACHIM FEURER</creatorcontrib><creatorcontrib>MARCO HENNEBOEHLE</creatorcontrib><creatorcontrib>MICHAEL SOEBERDT</creatorcontrib><creatorcontrib>PHILIPP WEYERMANN</creatorcontrib><creatorcontrib>HERVE SIENDT</creatorcontrib><creatorcontrib>HOLGER HERZNER</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CHRISTIAN RUMMEY</au><au>HOLGER DEPPE</au><au>MIROSLAV TERINEK</au><au>SONJA NORDHOFF</au><au>ACHIM FEURER</au><au>MARCO HENNEBOEHLE</au><au>MICHAEL SOEBERDT</au><au>PHILIPP WEYERMANN</au><au>HERVE SIENDT</au><au>HOLGER HERZNER</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>COMPOSTO, USO DO COMPOSTO, E, COMPOSIÇÃO FARMACÊUTICA</title><date>2015-01-27</date><risdate>2015</risdate><abstract>The present invention relates to substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators. Depending on the structure and the stereochemistry the compounds of the invention are either selective agonists or selective antagonists of the human melanocortin-4 receptor (MC-4R). The agonists can be used for the treatment of disorders and diseases such as obesity, diabetes and sexual dysfunction, whereas the antagonists are useful for the treatment of disorders and diseases such as cancer cachexia, muscle wasting, anorexia, anxiety and depression. Generally all diseases and disorders where the regulation of the MC-4R is involved can be treated with the compounds of the invention.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | por |
| recordid | cdi_epo_espacenet_BRPI0814382A2 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | COMPOSTO, USO DO COMPOSTO, E, COMPOSIÇÃO FARMACÊUTICA |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T18%3A46%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CHRISTIAN%20RUMMEY&rft.date=2015-01-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EBRPI0814382A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |